Clinical trials: Diffuse Intrinsic Pontine Gliomas (DIPG)

Diffuse Intrinsic Pontine Glioma (DIPG)

Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG).

• Completed
• Age: 1 month to 17 years
• Phase 1
• Injection or infusion

The goal of this pilot study is to determine if intra-arterial (IA) chemotherapy is safe in the treatment of progressive diffuse intrinsic pontine gliomas (DIPG).

Trial name

NCT01688401

Testing

Melphalan hydrochloride

Where

United States

Volunteers

3 people

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins